Vimarsana
Biggest News Aggregation in the World

Nikolaj Skydsgaard News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nikolaj Skydsgaard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nikolaj Skydsgaard Today - Breaking & Trending Today

Jewellery maker Pandora raises guidance after Q2 sales beat - Vimarsana News

Jewellery maker Pandora raises guidance after Q2 sales beat

Danish jewellery maker Pandora on Tuesday raised its full-year revenue outlook as it reported second-quarter sales above analyst forecasts. Pandora said it now expected organic sales... -Today at 01:37 am- MarketScreener

Novo Nordisk CEO Sees US Supply Curbs on Wegovy Into 2024 - Vimarsana News

Novo Nordisk CEO Sees US Supply Curbs on Wegovy Into 2024

Limits on US supplies of starter doses of its hugely popular weight-loss drug will last into next year, says Novo Nordisk CEO.

Novo Nordisk Eyes Other Wegovy Health Benefits After Major Trial - Vimarsana News

Novo Nordisk Eyes Other Wegovy Health Benefits After Major Trial

Novo Nordisk hopes to show additional health benefits from taking its hugely popular drug Wegovy, apart from losing weight and cutting the risk of heart disease, says executive.

Novo Nordisk's limits on Wegovy US supply seen into 2024, CEO says - Vimarsana News

Novo Nordisk's limits on Wegovy US supply seen into 2024, CEO says

COPENHAGEN (Reuters) -Novo Nordisk's limits on U.S. supplies of starter doses of its hugely popular Wegovy weight-loss drug will last into next year even as the Danish drugmaker spends billions boosting output, its CEO told Reuters on Thursday. Demand for Wegovy will be very high for the foreseeable future and higher than the Danish drugmaker can supply, Lars Fruergaard Jorgensen said in an interview after the company raised its full-year financial forecasts. Earlier on Thursday, the company said it would continue to restrict U.S. supplies of starter doses of Wegovy as the company strug...

Source: yahoo.com
Novo Nordisk CEO: US limits on weight-loss Wegovy use likely to last into 2024 - Vimarsana News

Novo Nordisk CEO: US limits on weight-loss Wegovy use likely to last into 2024

Novo Nordisk's limits on U.S. supplies of starter doses of its hugely popular Wegovy weight-loss drug will likely last into next year, CEO Lars Fruergaard Jorgensen told Reuters on Thursday. ... -Today at 04:54 am- MarketScreener